» Articles » PMID: 3516191

The Expression of ABH and Y Blood Group Antigens in Benign and Malignant Breast Tissue: the Preservation of the H and Y Antigens in Malignant Epithelium

Overview
Journal Br J Cancer
Specialty Oncology
Date 1986 Mar 1
PMID 3516191
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The ABO(H) and Y antigen status of epithelial cells from 45 breast carcinomas, 14 benign breast lesions and 7 normal breasts have been assessed using an indirect immunoperoxidase histochemical assay and a series of blood group specific monoclonal antibodies. All 20 A, AB and B group tumours had lost the A and B isoantigens, 13 of these tumours were however found to express H and Y antigens. Of 25 group O tumours 17 expressed the expected H and Y antigens. These findings were not dependent on the histological nature or the invasive characteristics of the tumour. Similar results were obtained when 28 metastases from breast carcinomas were examined, the H and Y antigens being identified in the tumour elements in 24 lymph nodes while we failed to identify either the A or B antigens. The development of breast malignancy appeared therefore to correlate best with the deletion of A and B glycosyl transferases. Normal breast tissue consistently expressed the expected blood group isoantigens. Areas of benign breast disease showed a more varied pattern of antigen expression. Seven of 14 lesions lacked ABH antigens, the loss of blood group structures could not however be correlated with any specific histological features and was not limited to the loss of A and B substances.

Citing Articles

The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study.

Dogan I, Ayhan M, Gurbuz M, Kucukarda A, Aydin E, Urun Y Medicine (Baltimore). 2022; 101(35):e30147.

PMID: 36107512 PMC: 9439766. DOI: 10.1097/MD.0000000000030147.


ABO blood classification and the risk of lung cancer: A meta-analysis and trial sequential analysis.

Yang H, Tan Z, Zhang Y, Sun J, Huang P Oncol Lett. 2022; 24(4):340.

PMID: 36072003 PMC: 9434722. DOI: 10.3892/ol.2022.13460.


Why do younger breast cancer patients with blood group O have favorable prognosis?.

Altundag K Med Oncol. 2017; 34(7):120.

PMID: 28536881 DOI: 10.1007/s12032-017-0979-1.


The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.

Vitiazeva V, Kattla J, Flowers S, Linden S, Premaratne P, Weijdegard B PLoS One. 2015; 10(6):e0130197.

PMID: 26075384 PMC: 4468167. DOI: 10.1371/journal.pone.0130197.


Tumor biomarker glycoproteins in the seminal plasma of healthy human males are endogenous ligands for DC-SIGN.

Clark G, Grassi P, Pang P, Panico M, Lafrenz D, Drobnis E Mol Cell Proteomics. 2011; 11(1):M111.008730.

PMID: 21986992 PMC: 3270097. DOI: 10.1074/mcp.M111.008730.


References
1.
DAVIDSOHN I, KOVARIK S, Ni L . Isoantigens A, B, and H in benign and malignant lesions of the cervix. Arch Pathol. 1969; 87(3):306-14. View

2.
Szulman A . THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE. III. THE A, B, AND H ANTIGENS IN EMBRYOS AND FETUSES FROM 18 MM IN LENGTH. J Exp Med. 1964; 119:503-16. PMC: 2137851. DOI: 10.1084/jem.119.4.503. View

3.
DAVIDSOHN I, STEJSKAL R . Tissue antigens A, B and H in health and disease. Haematologia (Budap). 1972; 6(1):177-84. View

4.
DAVIDSOHN I . Early immunologic diagnosis and prognosis of carcinoma. Philip Levine Award Address. Am J Clin Pathol. 1972; 57(6):715-30. DOI: 10.1093/ajcp/57.6.715. View

5.
Pann C, Kuhns W . Differentiation of HeLa cells with respect to blood group H antigen. Nat New Biol. 1972; 240(96):22-4. DOI: 10.1038/newbio240022a0. View